When it comes to the occurrence of brain tumors, everyone has their own ideas as to why it happens. While none of these can exactly be cemented, there is no question that they can occur and research is done in order to figure out more about these intricate growths. However, is it possible that a mutated gene in the body can play into how these tumors are formed as a result? Judging by a recent article on the matter, I believe it to be the case.
Science Daily posted an article that talked about how a mutated gene could potentially play into to the growth of a benign tumor in the brain. There are a number of affects that it could bring and this is the type of news that is rather unfortunate. However, the idea of certain drugs coming into play seems possible if the mutated gene mentioned before is focused on. Of course, there has to be details about the gene in question first before assessing the substances needed.
What are some of the details to consider about this mutated gene? It has been given the name of BRAF, which is one that was seen in almost all of the papillary craniopharyngioma samples seen. These are the ones that are more common in adult patients, as opposed to child patients who are more likely to be afflicted by another craniopharyngioma type known as adamantinomatous. This is what can help to make the selection of certain drugs easier and, as a result, possibly expand methods of remedy in the future.
I did not see just how serious craniopharyngiomas truly were until I read this report, especially when in relation to the gene mentioned before. Basically, a single BRAF can trigger these tumors, which is surprising to say the least. Those who have looked into the matter of brain tumors in the past might have considered how they would come to the surface because of multiple genes, not one. However, with a simpler approach seen, this is a story more than worth the attention of organizations such as Voices against Brain Cancer.
When it comes to studies seen in the scientific field, the simplest ones have the chance of yielding some of the best results. I do not think that anyone can argue with such a sentiment but is it one that can be easily linked to cancer in general? With so many different details to consider when looking at one tumor to another, it's hard to pinpoint what can be done to help. Mutated genes can come into play and it is here that focus will seemingly be the most concentrated.
Science Daily posted an article that talked about how a mutated gene could potentially play into to the growth of a benign tumor in the brain. There are a number of affects that it could bring and this is the type of news that is rather unfortunate. However, the idea of certain drugs coming into play seems possible if the mutated gene mentioned before is focused on. Of course, there has to be details about the gene in question first before assessing the substances needed.
What are some of the details to consider about this mutated gene? It has been given the name of BRAF, which is one that was seen in almost all of the papillary craniopharyngioma samples seen. These are the ones that are more common in adult patients, as opposed to child patients who are more likely to be afflicted by another craniopharyngioma type known as adamantinomatous. This is what can help to make the selection of certain drugs easier and, as a result, possibly expand methods of remedy in the future.
I did not see just how serious craniopharyngiomas truly were until I read this report, especially when in relation to the gene mentioned before. Basically, a single BRAF can trigger these tumors, which is surprising to say the least. Those who have looked into the matter of brain tumors in the past might have considered how they would come to the surface because of multiple genes, not one. However, with a simpler approach seen, this is a story more than worth the attention of organizations such as Voices against Brain Cancer.
When it comes to studies seen in the scientific field, the simplest ones have the chance of yielding some of the best results. I do not think that anyone can argue with such a sentiment but is it one that can be easily linked to cancer in general? With so many different details to consider when looking at one tumor to another, it's hard to pinpoint what can be done to help. Mutated genes can come into play and it is here that focus will seemingly be the most concentrated.
About the Author:
For further information about brain tumors, kindly visit Voices against Brain Cancer for specifics.
0 comments:
Post a Comment